Upper Eyelid Retraction in Graves' Ophthalmopathy: Our Surgical Experience on 153 Cases of Full-Thickness Anterior Blepharotomy with Mullerectomy.


Journal

Aesthetic plastic surgery
ISSN: 1432-5241
Titre abrégé: Aesthetic Plast Surg
Pays: United States
ID NLM: 7701756

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 03 11 2021
accepted: 03 01 2022
pubmed: 8 2 2022
medline: 28 9 2022
entrez: 7 2 2022
Statut: ppublish

Résumé

We present our experience on 153 cases of full-thickness anterior blepharotomy with mullerectomy (FTABM) in the treatment of upper eyelid retraction (UER) related to Graves' ophthalmopathy (GO). We included all the patients who underwent a graded FTABM between 1 Of the 111 patients, 42 underwent a bilateral procedure, while 69 a monolateral. Conjunctival symptoms were reported in 32% of cases before surgery and in 12.4% after FTABM (p < 0.001). Epiphora was complained by 29.6% of patients preoperatively and in 12.4% postoperatively (p < 0.001). Preoperative lagophthalmos was found in 12.4% (mean value of 0.34 ± 0.76 mm) of eyelids, and in 2.6% (mean value 0.05 ± 0.19 mm) eyelids (p = not significant) postoperatively. Pre-operative GO-QoL was 24.9 ± 4.4 mm; while post-operative GO-QoL was 35.3 ± 5.5 mm (p < 0.001). The MRD-1 varied from 10.12 ± 2.1 mm preoperatively, to 4.3 ± 0.6 mm (p < 0.001) after surgery. Asymmetric palpebral fissure was noted in 94 (84.7%) patients before surgery and in 7 (6.3%) after the procedure (p < 0.001). FTABM is an effective procedure to treat UER GO-related. The technique manages to prevent complications of UER and determine good aesthetics. This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 . Level IV, therapeutic study.

Sections du résumé

BACKGROUND
We present our experience on 153 cases of full-thickness anterior blepharotomy with mullerectomy (FTABM) in the treatment of upper eyelid retraction (UER) related to Graves' ophthalmopathy (GO).
METHODS
We included all the patients who underwent a graded FTABM between 1
RESULTS
Of the 111 patients, 42 underwent a bilateral procedure, while 69 a monolateral. Conjunctival symptoms were reported in 32% of cases before surgery and in 12.4% after FTABM (p < 0.001). Epiphora was complained by 29.6% of patients preoperatively and in 12.4% postoperatively (p < 0.001). Preoperative lagophthalmos was found in 12.4% (mean value of 0.34 ± 0.76 mm) of eyelids, and in 2.6% (mean value 0.05 ± 0.19 mm) eyelids (p = not significant) postoperatively. Pre-operative GO-QoL was 24.9 ± 4.4 mm; while post-operative GO-QoL was 35.3 ± 5.5 mm (p < 0.001). The MRD-1 varied from 10.12 ± 2.1 mm preoperatively, to 4.3 ± 0.6 mm (p < 0.001) after surgery. Asymmetric palpebral fissure was noted in 94 (84.7%) patients before surgery and in 7 (6.3%) after the procedure (p < 0.001).
CONCLUSION
FTABM is an effective procedure to treat UER GO-related. The technique manages to prevent complications of UER and determine good aesthetics.
LEVEL OF EVIDENCE IV
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 . Level IV, therapeutic study.

Identifiants

pubmed: 35129648
doi: 10.1007/s00266-022-02770-5
pii: 10.1007/s00266-022-02770-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1713-1721

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022. Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery.

Références

Chan W, Wong GW, Fan DS et al (2002) Ophthalmopathy in childhood Graves’ disease. Br J Ophthalmol 86:740–742
doi: 10.1136/bjo.86.7.740
Cockerham KP, Hidayat AA, Brown HG, Cockerham GC, Graner SR (2002) Clinicopathologic evaluation of the mueller muscle in thyroid-associated orbitopathy. Ophthal Plast Reconstr Surg 18:11–17
doi: 10.1097/00002341-200201000-00003
Kroll AJ, Kuwabara T (1966) Dysthyroid ocular myopathy: anatomy, histology and electron microscopy. Arch Ophthalmol 76:244–257
doi: 10.1001/archopht.1966.03850010246017
Tengroth B (1964) Histological studies of orbital tissue in a case of endocrine exophthalmos before and after remission. Acta Ophthalmol 42:588–591
doi: 10.1111/j.1755-3768.1964.tb00907.x
Grove AS (1981) Upper eyelid retraction and Graves’ disease. Ophthalmology 88:499–506
doi: 10.1016/S0161-6420(81)34991-4
Simon GJB, Mansury AM, Schwarcz RM, Modjtahedi S, McCann JD, Goldberg RA (2005) Transconjunctival müller muscle recession with levator disinsertion for correction of eyelid retraction associated with thyroid-related orbitopathy. Am J Ophtalmol 140:94e1-94e7
doi: 10.1016/j.ajo.2005.02.034
Bartley G, Fatourechi V, Kadrmas EF et al (1996) Clinical features of Graves’ ophthalmopathy in an incidence cohort. Am J Ophthalmol 121:284–290
doi: 10.1016/S0002-9394(14)70276-4
Shorr N, Seiff SR (1986) The four stages of surgical rehabilitation of the patient with dysthyroid orbitopathy. Ophthalmology 93:476–483
doi: 10.1016/S0161-6420(86)33712-6
Yeatts R (1995) Graves’ ophthalmopathy. Med Clin North Am 79:195–209
doi: 10.1016/S0025-7125(16)30092-X
Shorr N, Neuhaus RW, Baylis HI (1982) Ocular motility problems after orbital decompression for dysthyroid ophthalmopathy. Ophthalmology 89:323–328
doi: 10.1016/S0161-6420(82)34793-4
Terwee CB, Gerding MN, Dekker FW, Prummel MF, Wiersinga WM (1998) Development of a disease specific quality of life questionnaire for patients with Graves’ ophthalmopathy: the GO-QOL. Br J Ophthalmol 82:773–779
doi: 10.1136/bjo.82.7.773
Mourits MP, Sasim IV (1999) A single technique to correct various degrees of upper lid retraction in patients with Graves. Br J Ophthalmol 83:81–84
doi: 10.1136/bjo.83.1.81
Knop E, Knop N (2002) A functional unit for ocular surface immune defence formed by the lacrimal gland, conjunctiva and lacrimal drainage system. Adv Exp Med Biol 506:635–644
Koornneef L (1977) The architecture of the muscolo-fibrous apparatus in the human orbit. Acta Morphol Neerls Scand 15:35–64
Putterman AM (1977) Surgical treatment of dysthyroid eyelid retraction and orbital fat hernia. Am Acad Ophthalmol Otolarynogol 228-236
Putterman AM (1981) Surgical treatment of thyroid-related upper eyelid retraction graded Muller’s muscle excision and levator recession. Ophtalmology 88:507–512
doi: 10.1016/S0161-6420(81)34987-2
Gay AJ, Wolkstein MA (1966) Topical guanethidine therapy for endocrine lid retraction. Arch Ophthalmol 76:364–367
doi: 10.1001/archopht.1966.03850010366012
Ebner R (1993) Botulinum toxin type A in upper lid retraction of Graves’ ophthalmopathy. J Clin Neuroophthalmol 13:258–261
pubmed: 8113438
Uddin JM, Davies PD (2002) Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection. Ophthalmology 109:1183–1187
doi: 10.1016/S0161-6420(02)01041-2
Putterman A, Fett DR (1986) Müller’s muscle in the treatment of upper eyelid retraction: a 12-year study. Ophthalmic Surg 17:361–367
pubmed: 3755520
Baylis HI, Cies WA, Kamin DF (1976) Correction of upper eyelid retraction. Am J Ophthalmol 82:790–794
doi: 10.1016/0002-9394(76)90019-2
Grove AS Jr (1980) Eyelid retraction treated by levator marginal myotomy. Ophthalmology 87:1013–1018
doi: 10.1016/S0161-6420(80)35136-1
Elner VM, Hassan AS, Frueh BR (2004) Graded full-thickness anterior blepharotomy for upper eyelid retraction. Arch Ophthalmol 122:55–60
doi: 10.1001/archopht.122.1.55
Hassan AS, Frueh BR, Elner VM (2005) Mullerectomy for upper eyelid retraction and lagophthalmos due to facial nerve palsy. Arch Ophthalmol 123:1221–1225
doi: 10.1001/archopht.123.9.1221
Golan S, Rootman DB, Goldberg RA (2016) The success rate of TED upper eyelid retraction reoperations. Orbit 35:335–338
doi: 10.1080/01676830.2016.1193546
Novaes de Figueiredo M (2017) Tarsal platform show after upper eyelid blepharoplasty with or without brassiere sutures. Arq Bras Oftalmol 80:345–349
Lee JKS (2019) Optimizing esthetic outcomes in graded full-thickness anterior blepharotomy for Graves’ ophthalmopathy. Graefe’s Archiv Clin Expl Ophthalmol 257:1303–1308
doi: 10.1007/s00417-019-04308-z
Evans JA, Clark TJE, Zimmerman MB, Allen RC, Nerad JA, Carter KD, Shriver EM (2018) Rethinking our definition of postoperative success: a comparative analysis of three upper eyelid retraction repair techniques using novel metrics to capture functional and aesthetic outcomes. Ophthal Plast Reconstr Surg 34:55–63
doi: 10.1097/IOP.0000000000000868
Goldber RA (2011) Cosmetic outcome of posterior approach ptosis surgery (an American Ophthalmological Society thesis. Trans Am Ophthalmol Soc. 109:157-167
Papageorgiou K (2012) Aesthetic considerations in upper eyelid retraction surgery. Ophthal Plast Reconstr Surg 28:419–423
doi: 10.1097/IOP.0b013e318263c56e
Nimitwongsakul A, Zoumalan CI, Kazim M (2013) Modified full-thickness blepharotomy for treatment of thyroid eye disease. Ophthal Plast Reconstr Surg 29:44–47
doi: 10.1097/IOP.0b013e318275b5e2

Auteurs

Claudio Guastella (C)

Department of Otorhinolaryngology - Head and Neck Surgery, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milano, Italy.
Referral Centre for Graves' Ophthalmopathy, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.

Domenico di Furia (D)

Department of Otorhinolaryngology - Head and Neck Surgery, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milano, Italy.
Department of Clinical Sciences and Community Health, University of Milan, Milano, Italy.

Sara Torretta (S)

Department of Otorhinolaryngology - Head and Neck Surgery, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milano, Italy.
Department of Clinical Sciences and Community Health, University of Milan, Milano, Italy.

Tullio Mattia Ibba (TM)

Department of Otorhinolaryngology - Head and Neck Surgery, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milano, Italy.

Lorenzo Pignataro (L)

Department of Otorhinolaryngology - Head and Neck Surgery, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milano, Italy.
Referral Centre for Graves' Ophthalmopathy, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
Department of Clinical Sciences and Community Health, University of Milan, Milano, Italy.

Remo Accorona (R)

Department of Otorhinolaryngology - Head and Neck Surgery, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milano, Italy. dott.remoaccorona@gmail.com.
Referral Centre for Graves' Ophthalmopathy, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy. dott.remoaccorona@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH